Asset Details
Do you wish to reserve the book?
Intensive Care Unit―acquired Weakness: Clinical Phenotypes and Molecular Mechanisms
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Intensive Care Unit―acquired Weakness: Clinical Phenotypes and Molecular Mechanisms
Do you wish to request the book?
Intensive Care Unit―acquired Weakness: Clinical Phenotypes and Molecular Mechanisms
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Intensive Care Unit―acquired Weakness: Clinical Phenotypes and Molecular Mechanisms
2013
Overview
Intensive care unit-acquired weakness (ICUAW) begins within hours of mechanical ventilation and may not be completely reversible over time. It represents a major functional morbidity of critical illness and is an important patient-centered outcome with clear implications for quality of life and resumption of prior work and lifestyle. There is heterogeneity in functional outcome related to ICUAW across various patient populations after an episode of critical illness. This state-of-the art review argues that this observed heterogeneity may represent a clinical spectrum of disability in which there are recognizable clinical phenotypes for outcome according to age, burden of comorbid illness, and ICU length of stay. It further argues that these functional outcomes are modified by mood, cognition, and caregiver physical and mental health. This proposed construct of clinical phenotypes will be used as a framework for a review of the current literature on the molecular biology of muscle and nerve injury. This translational approach for the development of models pairing clinical phenotypes for different functional outcomes after critical illness with molecular mechanism of injury may offer unique insights into the diagnosis and treatment of muscle and nerve lesions.
Publisher
American Thoracic Society,Oxford University Press
Subject
/ Adult
/ Age
/ Aged
/ Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
/ Biological and medical sciences
/ Clinical death. Palliative care. Organ gift and preservation
/ Humans
/ Muscle Weakness - physiopathology
/ Muscular Atrophy - physiopathology
/ Patients
/ Polyneuropathies - physiopathology
/ Respiration, Artificial - adverse effects
/ Sepsis
